Prevalence of Alzheimer's disease in very elderly people: A prospective neuropathological study

Neurology

Volumn 56, Issue 12, 2001, Pages 1690-1696

  Polvikoski, T ^a   Sulkava, R ^b   Myllykangas, L ^a,d   Notkola, I L ^a   Niinisto L ^c   Verkkoniemi, A ^a   Kainulainen, K ^a   Kontula, K ^a   Perez Tur J ^d,e   Hardy, J ^d   Haltia, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Katriina Geriatric Hospital   (Finland)

^d MAYO CLINIC   (United States)

^e INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 0035954350     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.12.1690     Document Type: Article

References (38)

1. A population-based study of dementia in 85-year-olds
2. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study
3. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex and education
4. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam Study
5. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported
6. Absence of vascular dementia in an autopsy series from a dementia clinic
7. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
8. Multicenter clinicopathological correlation in dementia
9. Incorrect diagnosis of Alzheimer's disease. A clinicopathological study
10. Argyrophilic grain disease: Frequency of occurrence in different age categories and neuropathological diagnostic criteria
11. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease
12. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease
13. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
14. Apolipoprotein E-ε4 allele and Alzheimer's disease
15. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study
16. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein
17. Apolipoprotein E association with dementia in a population-based study: The Framingham Study
18. Effects of age, gender and ethnicity on the association between apolipoprotein-E genotype and Alzheimer's disease
19. Lack of association of apolipoprotein E allele ε4 with late-onset Alzheimer's disease among Finnish centenarians
20. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
21. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
22. Neuropathological staging of Alzheimer-related changes
23. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
24. Vascular dementia: Diagnostic criteria for research studies: Report of the NINCDS-AIREN International Workshop
25. "Mini Mental State": A practical method for grading the cognitive state of patients for the clinician
26. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients
27. A new clinical scale for the staging of dementia
28. Studies of illness in the aged
29. Assessment of older people: Self maintaining and instrumental activities of daily living
30. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing
31. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
32. Clinical validity of Braak neuropathological staging in the oldest-old
33. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia
34. ApoE-ε4 count predicts age when prevalence of AD increases, then declines. The Cache County Study
35. Undifferentiated dementia, Alzheimer's disease and vascular dementia: Age- and gender-related incidence in Liverpool. The MRC-ALPHA Study
36. A high incidence of apolipoprotein E ε4 allele in middle-aged non-demented subjects with cerebral amyloid β protein deposits
37. ApoE genotype predicts when-not whether-one is predisposed to develop Alzheimer's disease